These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 38761234)
1. An exosomes-related lncRNA prognostic model correlates with the immune microenvironment and therapy response in lung adenocarcinoma. Chu D; Chen L; Li W; Zhang H Clin Exp Med; 2024 May; 24(1):104. PubMed ID: 38761234 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
3. Identification of a Risk Signature and Immune Cell Infiltration Based on Extracellular Matrix-Related lncRNAs in Lung Adenocarcinoma. Zhang M; Cen T; Huang SH; Wang C; Wu X; Zhao X; Xu Z; Zhang X Crit Rev Eukaryot Gene Expr; 2025; 35(1):49-65. PubMed ID: 39630036 [TBL] [Abstract][Full Text] [Related]
4. Pyroptosis-related long-noncoding RNA signature predicting survival and immunotherapy efficacy in patients with lung squamous cell carcinoma. Zhan X; Li J; Ding Y; Zhou F; Zeng R; Lei L; Zhang Y; Feng A; Qu Y; Yang Z Clin Exp Med; 2024 Jul; 24(1):145. PubMed ID: 38960987 [TBL] [Abstract][Full Text] [Related]
5. Construction of an immunogenic cell death-related LncRNA signature to predict the prognosis of patients with lung adenocarcinoma. Wang S; Zhang Y BMC Med Genomics; 2024 Nov; 17(1):277. PubMed ID: 39604972 [TBL] [Abstract][Full Text] [Related]
6. High expression of malic enzyme 1 predicts adverse prognosis in patients with cytogenetically normal acute myeloid leukaemia and promotes leukaemogenesis through the IL-6/JAK2/STAT3 pathways. Zhang C; Li W; Wu F; Lu Z; Zeng P; Luo Z; Cao Y; Wen F; Li J; Chen X; Wang F Ther Adv Hematol; 2024; 15():20406207241301948. PubMed ID: 39610460 [TBL] [Abstract][Full Text] [Related]
7. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences. Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159 [TBL] [Abstract][Full Text] [Related]
8. An immune scoring system predicts prognosis and immune characteristics in lung adenocarcinoma brain metastases by RNA sequencing. Xiao G; Tanzhu G; Gao X; Li L; Liu Z; Xia X; Zhou R Acta Neuropathol Commun; 2024 Nov; 12(1):181. PubMed ID: 39593098 [TBL] [Abstract][Full Text] [Related]
9. A novel disulfidptosis-related LncRNA prognostic risk model: predicts the prognosis, tumor microenvironment and drug sensitivity in esophageal squamous cell carcinoma. Ye C; Xu C; Tang Y; Qi Y; Peng X; Wei G; Jiang L BMC Gastroenterol; 2024 Nov; 24(1):437. PubMed ID: 39604874 [TBL] [Abstract][Full Text] [Related]
10. Develop a Novel Signature to Predict the Survival and Affect the Immune Microenvironment of Osteosarcoma Patients: Anoikis-Related Genes. Yang M; Su Y; Xu K; Zheng H; Cai Y; Wen P; Yang Z; Liu L; Xu P J Immunol Res; 2024; 2024():6595252. PubMed ID: 39431237 [TBL] [Abstract][Full Text] [Related]
11. Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication. Ryan R; Hill S Cochrane Database Syst Rev; 2019 Oct; 10(10):ED000141. PubMed ID: 31643081 [TBL] [Abstract][Full Text] [Related]
12. "I've Spent My Whole Life Striving to Be Normal": Internalized Stigma and Perceived Impact of Diagnosis in Autistic Adults. Huang Y; Trollor JN; Foley KR; Arnold SRC Autism Adulthood; 2023 Dec; 5(4):423-436. PubMed ID: 38116050 [TBL] [Abstract][Full Text] [Related]
13. Integrating machine learning and multi-omics analysis to develop an asparagine metabolism immunity index for improving clinical outcome and drug sensitivity in lung adenocarcinoma. Li C; Mao Y; Hu J; Su C; Li M; Tan H Immunol Res; 2024 Dec; 72(6):1447-1469. PubMed ID: 39320693 [TBL] [Abstract][Full Text] [Related]
14. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661 [TBL] [Abstract][Full Text] [Related]
15. Single-cell RNA sequencing reveals immune microenvironment niche transitions during the invasive and metastatic processes of ground-glass nodules and part-solid nodules in lung adenocarcinoma. Ren YF; Ma Q; Zeng X; Huang CX; Ren JL; Li F; Tong JJ; He JW; Zhong Y; Tan SY; Jiang H; Zhang LF; Lai HZ; Xiao P; Zhuang X; Wu P; You LT; Shi W; Fu X; Zheng C; You FM Mol Cancer; 2024 Nov; 23(1):263. PubMed ID: 39580469 [TBL] [Abstract][Full Text] [Related]
17. Identifying the prognostic significance of mitophagy-associated genes in multiple myeloma: a novel risk model construction. Min R; Hu Z; Zhou Y Clin Exp Med; 2024 Oct; 24(1):249. PubMed ID: 39470826 [TBL] [Abstract][Full Text] [Related]
18. SEC61 translocon gamma subunit is correlated with glycolytic activity, epithelial mesenchymal transition and the immune suppressive phenotype of lung adenocarcinoma. Zhou C; Cui H; Yang Y; Chen L; Feng M; Gao Y; Li D; Li L; Chen X; Li X; Cao Y Acta Biochim Biophys Sin (Shanghai); 2024 Jul; 56(12):1748-1760. PubMed ID: 38978503 [TBL] [Abstract][Full Text] [Related]